Physician profile
Anthony L Doerr
NPI 1194773929
$8,584.00
in general payments reported to CMS, 2019-2025
44 companies · $801 in 2025
The $801 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,366 · 2020: $816 · 2021: $1,367 · 2022: $1,656 · 2023: $1,406 · 2024: $1,173 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,280 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,280.28 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,512.02 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $1,188.02 | 2019-2020 | |
| Astellas Pharma US INC | $1,162.43 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $707.29 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $468.31 | 2021-2022 | |
| Neotract INC. | $265.74 | 2019 | |
| Abbvie INC. | $214.62 | 2019-2024 | Botox |
| Allergan, INC. | $158.34 | 2019-2022 | |
| Urogen Pharma, INC. | $156.52 | 2021-2025 | |
| Procept Biorobotics Corporation | $154.45 | 2022-2025 | |
| Pfizer INC. | $127.15 | 2019-2023 | |
| Coloplast Corp | $123.87 | 2021-2024 | Speedicath |
| Abc Home Medical Supply, INC. | $100.97 | 2024-2025 | |
| Rochester Medical Corporation | $100.50 | 2019-2021 | |
| Tolmar, INC. | $98.80 | 2023-2024 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Doerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.